# Bioequivalence of Two Levothyroxine Tablet Formulations in Healthy Indian Volunteers

> **NCT01536678** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 26 (actual)

## Conditions studied

- Hypothyroidism

## Interventions

- **DRUG:** Levothyroxine
- **DRUG:** Levothyroxine

## Key facts

- **NCT ID:** NCT01536678
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2013-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01536678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01536678, "Bioequivalence of Two Levothyroxine Tablet Formulations in Healthy Indian Volunteers". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT01536678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*